151 related articles for article (PubMed ID: 8841050)
1. [Combination of irinotecan hydrochloride (CPT-11) and cisplatin as a new regimen for patients with advanced ovarian cancer].
Sugiyama T; Nishida T; Kataoka A; Imaishi K; Komai K; Ushijima K; Hasuo Y; Ookura N; Yakushiji M
Nihon Sanka Fujinka Gakkai Zasshi; 1996 Sep; 48(9):827-34. PubMed ID: 8841050
[TBL] [Abstract][Full Text] [Related]
2. [Usefulness of clinical study of irinotecan and cisplatin for recurrent ovarian cancer].
Yahagi N; Kobayashi Y; Ohara T; Kondo H; Suzuki N; Kiguchi K; Ishizuka B
Gan To Kagaku Ryoho; 2009 Dec; 36(13):2583-6. PubMed ID: 20009459
[TBL] [Abstract][Full Text] [Related]
3. Irinotecan (CPT-11) combined with cisplatin in patients with refractory or recurrent ovarian cancer.
Sugiyama T; Yakushiji M; Nishida T; Ushijima K; Okura N; Kigawa J; Terakawa N
Cancer Lett; 1998 Jun; 128(2):211-8. PubMed ID: 9683285
[TBL] [Abstract][Full Text] [Related]
4. Irinotecan (CPT-11) in combination with weekly administration of cisplatin (CDDP) for non-small-cell lung cancer.
Kobayashi K; Shinbara A; Kamimura M; Takeda Y; Kudo K; Kabe J; Hibino S; Hino M; Shibuya M; Kudoh S
Cancer Chemother Pharmacol; 1998; 42(1):53-8. PubMed ID: 9619758
[TBL] [Abstract][Full Text] [Related]
5. [Results of neoadjuvant chemotherapy using tri-weekly CDDP/CPT-11 for locally advanced cervical cancer].
Shoji T; Takatori E; Murai M; Hatayama S; Omi H; Kagabu M; Honda T; Kumagai S; Morohara Y; Yoshizaki A; Sugiyama T; Kaido Y; Miura F; Satoh A
Gan To Kagaku Ryoho; 2010 Apr; 37(4):643-8. PubMed ID: 20414019
[TBL] [Abstract][Full Text] [Related]
6. Phase I study of irinotecan and cisplatin with granulocyte colony-stimulating factor support for advanced non-small-cell lung cancer.
Masuda N; Fukuoka M; Kudoh S; Kusunoki Y; Matsui K; Nakagawa K; Hirashima T; Tamanoi M; Nitta T; Yana T
J Clin Oncol; 1994 Jan; 12(1):90-6. PubMed ID: 7505810
[TBL] [Abstract][Full Text] [Related]
7. Phase I clinical trial of irinotecan (CPT-11), 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxy-camptothecin, and cisplatin in combination with fixed dose of vindesine in advanced non-small cell lung cancer.
Shinkai T; Arioka H; Kunikane H; Eguchi K; Sasaki Y; Tamura T; Ohe Y; Oshita F; Nishio M; Karato A
Cancer Res; 1994 May; 54(10):2636-42. PubMed ID: 8168091
[TBL] [Abstract][Full Text] [Related]
8. Combination chemotherapy with irinotecan and cisplatin in pretreated patients with unresectable or recurrent gastric cancer.
Ueda S; Hironaka S; Boku N; Fukutomi A; Yoshino T; Onozawa Y
Gastric Cancer; 2006; 9(3):203-7. PubMed ID: 16952039
[TBL] [Abstract][Full Text] [Related]
9. [Promising new drugs for gynecological cancer].
Yakushiji M; Sugiyama T; Ushijima K
Gan To Kagaku Ryoho; 1997 Oct; 24(13):1932-7. PubMed ID: 9350238
[TBL] [Abstract][Full Text] [Related]
10. A phase I study of irinotecan and pegylated liposomal doxorubicin in recurrent ovarian cancer (Tohoku Gynecologic Cancer Unit 104 study).
Shoji T; Takatori E; Kaido Y; Omi H; Yokoyama Y; Mizunuma H; Kaiho M; Otsuki T; Takano T; Yaegashi N; Nishiyama H; Fujimori K; Sugiyama T
Cancer Chemother Pharmacol; 2014 May; 73(5):895-901. PubMed ID: 24585045
[TBL] [Abstract][Full Text] [Related]
11. Relationship between the pharmacokinetics of irinotecan and diarrhea during combination chemotherapy with cisplatin.
Kudoh S; Fukuoka M; Masuda N; Yoshikawa A; Kusunoki Y; Matsui K; Negoro S; Takifuji N; Nakagawa K; Hirashima T
Jpn J Cancer Res; 1995 Apr; 86(4):406-13. PubMed ID: 7775263
[TBL] [Abstract][Full Text] [Related]
12. [Improvement in the regimen for combined CDDP and CPT-11 chemotherapy].
Shimizu A; Sugitoh Y; Hasegawa A; Okubo K; Fujihara T; Ishikawa T; Suzuki N; Yoda A; Narabayashi A; Takahashi J; Notake Y
Gan To Kagaku Ryoho; 2000 Oct; 27(12):1807-11. PubMed ID: 11086417
[TBL] [Abstract][Full Text] [Related]
13. [Clinical evaluation of irinotecan combined with cisplatin by divided administration in patients with untreated primary non-small cell lung cancer].
Asano T; Namikawa O; Yamamoto A; Sano T; Mukai J; Kawaji K; Kobayashi M
Nihon Kokyuki Gakkai Zasshi; 1998 Sep; 36(9):771-5. PubMed ID: 9866979
[TBL] [Abstract][Full Text] [Related]
14. A pilot study of CPT-11 and cisplatin for ovarian clear cell adenocarcinoma.
Adachi S; Ogasawara T; Yamasaki N; Shibahara H; Kanazawa R; Tsuji Y; Takemura T; Koyama K
Jpn J Clin Oncol; 1999 Sep; 29(9):434-7. PubMed ID: 10563197
[TBL] [Abstract][Full Text] [Related]
15. Phase II study of a combination of irinotecan and cisplatin against metastatic gastric cancer.
Boku N; Ohtsu A; Shimada Y; Shirao K; Seki S; Saito H; Sakata Y; Hyodo I
J Clin Oncol; 1999 Jan; 17(1):319-23. PubMed ID: 10458249
[TBL] [Abstract][Full Text] [Related]
16. Irinotecan (CPT-11) and cisplatin as first-line chemotherapy for advanced ovarian cancer.
Sugiyama T; Yakushiji M; Kamura T; Ikeda M; Umesaki N; Hasegawa K; Ishikawa M; Saji F; Hiura M; Takahashi T; Sato S; Ochiai K; Kikkawa F; Takeuchi S; Ohashi Y; Noda K;
Oncology; 2002; 63(1):16-22. PubMed ID: 12187066
[TBL] [Abstract][Full Text] [Related]
17. Phase II clinical study of neoadjuvant chemotherapy with CDDP/CPT-11 regimen in combination with radical hysterectomy for cervical cancer with a bulky mass.
Shoji T; Takatori E; Furutake Y; Takada A; Nagasawa T; Omi H; Kagabu M; Honda T; Miura F; Takeuchi S; Kumagai S; Yoshizaki A; Sato A; Sugiyama T
Int J Clin Oncol; 2016 Dec; 21(6):1120-1127. PubMed ID: 27342833
[TBL] [Abstract][Full Text] [Related]
18. [Neoadjuvant chemotherapy with cisplatin and CPT-11 for advanced cervical cancer].
Nishio S; Kumagai S; Hirai N; Tomioka Y; Oota S; Fujiyoshi K; Hasuo Y; Sugiyama T; Nishida T; Kamura T
Gan To Kagaku Ryoho; 2000 Mar; 27(3):429-35. PubMed ID: 10740637
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic study of two infusion schedules of irinotecan combined with cisplatin in patients with advanced gastric cancer.
Fujitani K; Tsujinaka T; Hirao M
Oncology; 2003; 64(2):111-5. PubMed ID: 12566907
[TBL] [Abstract][Full Text] [Related]
20. Third-line chemotherapy with paclitaxel, irinotecan hydrochloride and cisplatin for recurrent gastric cancer: a case report.
Takahashi N; Suzuki H; Iwabuchi S; Yamazaki Y; Yanaga K
Hepatogastroenterology; 2005; 52(61):326-8. PubMed ID: 15783061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]